tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Cash flow

Compare
1,068 Followers

Xeris Pharmaceuticals Cash Flow

XERS's free cash flow for Q3 2025 was $18.07M. For the 2025 fiscal year, XERS's free cash flow was decreased by $11.44M and operating cash flow was $18.43M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 23Dec 23Dec 23
Operating Cash Flow
$ -36.98M$ -47.02M$ -47.02M$ -47.02M$ -47.02M
Investing Cash Flow
$ 4.88M$ -6.00M$ -6.00M$ -6.00M$ -6.00M
Financing Cash Flow
$ 36.17M$ -1.61M$ -1.61M$ -1.61M$ -1.61M
End Cash Position
$ 75.74M$ 71.67M$ 71.67M$ 71.67M$ 71.67M
Free Cash Flow
$ -37.85M$ -49.29M$ -49.29M$ -49.29M$ -49.29M
Currency in USD

Xeris Pharmaceuticals Cash Flow